Publications by authors named "Musa Mayer"

24Publications

Development, implementation and evaluation of an online course on evidence-based healthcare for consumers.

BMC Health Serv Res 2020 Oct 8;20(1):928. Epub 2020 Oct 8.

Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, 624 N Broadway, 707, Baltimore, MD, 21205, USA.

View Article and Find Full Text PDF
October 2020

Differential presentation and survival of de novo and recurrent metastatic breast cancer over time: 1990-2010.

Breast Cancer Res Treat 2018 01 16;167(2):579-590. Epub 2017 Oct 16.

Swedish Cancer Institute, Seattle, WA, USA.

View Article and Find Full Text PDF
January 2018

Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States.

Cancer Epidemiol Biomarkers Prev 2017 06 18;26(6):809-815. Epub 2017 May 18.

Metastatic Breast Cancer Alliance, New York, New York.

View Article and Find Full Text PDF
June 2017

Trastuzumab Emtansine (T-DM1) in Patients With HER2-Positive Metastatic Breast Cancer Previously Treated With Chemotherapy and 2 or More HER2-Targeted Agents: Results From the T-PAS Expanded Access Study.

Cancer J 2015 Sep-Oct;21(5):357-64

From the *Breast Cancer Research, Sarah Cannon Research Institute; and †Medical Oncology, Tennessee Oncology, PLLC, Nashville, TN; ‡Dana-Farber Cancer Institute, Boston, MA; §Smilow Cancer Center, Yale University, New Haven, CT; ∥AdvancedBC.org, New York, NY; ¶Genentech, Inc, South San Francisco, CA; and #Mayo Clinic, Jacksonville, FL.

View Article and Find Full Text PDF
June 2016

Treatment patterns and clinical outcomes for patients with de novo versus recurrent HER2-positive metastatic breast cancer.

Breast Cancer Res Treat 2014 Jun 6;145(3):725-34. Epub 2014 Apr 6.

Sarah Cannon Research Institute, 250 25th Avenue N, Suite 100, Nashville, TN, 37203, USA,

View Article and Find Full Text PDF
June 2014

Racial disparities in treatment patterns and clinical outcomes in patients with HER2-positive metastatic breast cancer.

Breast Cancer Res Treat 2013 Oct 24;141(3):461-70. Epub 2013 Sep 24.

University of California San Francisco Helen Diller Family Comprehensive Cancer Center, 1600 Divisadero Street, Box 1710, San Francisco, CA, 94143-1710, USA,

View Article and Find Full Text PDF
October 2013

Breast cancer metastasis: issues for the personalization of its prevention and treatment.

Am J Pathol 2013 Oct 26;183(4):1084-1095. Epub 2013 Jul 26.

Women's Cancers Section, Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article and Find Full Text PDF
October 2013

First-line treatment patterns and clinical outcomes in patients with HER2-positive and hormone receptor-positive metastatic breast cancer from registHER.

Oncologist 2013 7;18(5):501-10. Epub 2013 May 7.

University of Southern California, Norris Comprehensive Cancer Center, Department of Medicine, Los Angeles, California 90033, USA.

View Article and Find Full Text PDF
December 2013

Shaping the future of biomarker research in breast cancer to ensure clinical relevance.

Nat Rev Cancer 2007 04;7(4):309-15

National Breast Cancer Coalition Fund 1101 17th Street, NW, Suite 1300 Washington, DC 20036, USA.

View Article and Find Full Text PDF
April 2007